Agilent news and events in 2026
Agilent designs and manufactures analytical, research, and diagnostic tools used in laboratory settings. The organization produces a variety of equipment, including liquid chromatography and gas chromatography mass spectrometry systems, atomic spectroscopy instruments, and cell analysis tools.
Public (A)Biotechnology Research10,000+ employeesagilent.comLinkedIn
- Dated updates
- 96
- Last event
- Sep 29, 2026
- Open rolesSnapshot Sep 29, 2026
- 110
- Latest SEC filing
- Sep 8, 2026
Overview
Agilent by topic
110open roles
1executive move
58+signals
44 in the last 90 days
- LinkedIn15+
- Glassdoor14
- Employee growth12
- Patents10
- and 2 more sources
Latest events
Latest Agilent events
Showing 10 of 29 events. The Signal API returns all of them.
Get them with one API call- LaunchAgilent Technologies stock gains on digital pathology launch and strong Q3 figuresAgilent Technologies launched its Agilent S540MD Slide Scanner System in the U.S. after receiving FDA clearance.
- LaunchAgilent launches new ICP-MS, GC Systems and Digital Lab Execution platform in IndiaAgilent Technologies has launched three new laboratory solutions in India: the Agilent 9500 Triple Quadrupole ICP-MS, new 8890B and 8860B Gas Chromatography Systems, and the OpenLab Sync Lab Execution System.
- RevenueAgilent reports Q3 fiscal 2026 revenue $1.88B, raises FY26 guidance, non-GAAP EPS $1.62Agilent Technologies reported third-quarter fiscal 2026 revenue of $1.88 billion, an 8.1% increase year-over-year.
- RevenueEarnings To Watch: Agilent (A) Reports Q2 Results TomorrowAgilent Technologies reported revenues of $1.84 billion in its previous quarter, a 10% increase year-on-year.
- RevenueAgilent Technologies stock touches fresh 52-week high as investors position ahead of Q3 earningsAgilent Technologies' Applied Markets segment is expected to report net revenue of $336.29 million in the upcoming quarter, a 3.8% year-over-year increase.
- LaunchAgilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaAgilent Technologies Inc. has received European Union (EU) certification for its PD-L1 IHC 22C3 pharmDx, a companion diagnostic to identify patients with certain types of carcinoma who may be eligible for treatment with Merck's KEYTRUDA.
- LaunchAgilent Technologies (NYSE:A) Gains Fresh FDA MomentumAgilent Technologies has secured regulatory clearance from the FDA for its PD-L1 IHC pharmDx assay, a precision oncology companion diagnostic for several gastrointestinal cancers.
- LaunchAgilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal AdenocarcinomaAgilent Technologies received FDA approval for its PD-L1 IHC 28-8 pharmDx assay as a companion diagnostic for certain types of esophageal and gastric cancers.
- Partnership
- Launch
Showing 10 of 29 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Agilent with the Signal API
One POST /v1/companies/enrich call with agilent.com returns every signal type for Agilent, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"agilent.com","limit":20}'Same industry
Companies related to Agilent
Agilent questions
What is the latest news on Agilent?
What is going on with Agilent?
What else does Autobound track for Agilent?
Is Agilent hiring right now?
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .